Valion Bio (VBIO) Net Margin (2021 - 2025)
Valion Bio (VBIO) recorded Net Margin of -1778.08% in Q3 2025, down 642.37 percentage points from -1135.71% a year earlier but up 468.43 percentage points from the prior quarter.
Valion Bio (VBIO) Net Margin (2021 - 2025) Analysis & Trends
On a TTM basis, Valion Bio's Net Margin came in at -1562.24% as of Sep 30, 2025, down 891.29 percentage points year-over-year; for FY2024, it came in at -730.77%, down 29.75 percentage points from FY2023.
- Annual Net Margin has a three-year change of -55.03 percentage points (FY2021 to FY2024).
- Across earlier years, Net Margin came in at -701.02% in FY2023 (-152.11 pp), -548.91% in FY2022 (+126.82 pp) and -675.74% in FY2021.
- Quarterly Net Margin has ranged from -2246.51% in Q2 2025 to -408.21% in Q2 2021 over the past five years.
- On a year-over-year basis, Net Margin has declined for five consecutive quarters, with an average year-over-year change of -492.93 percentage points over the last eight quarters.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 415.59 percentage points in Q2 2024, against a drop of 1702.30 percentage points in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -2246.51% (Q2 2025), -2145.71% (Q1 2025) and -833.33% (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 32.99% |
| 10 | Valion Bio | 378,559.99 | -19.06 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,778.08% |
| Jun 30, 2025 | -2,246.51% |
| Mar 31, 2025 | -2,145.71% |
| Dec 31, 2024 | -833.33% |
| Sep 30, 2024 | -1,135.71% |
| Jun 30, 2024 | -904.29% |
| Mar 31, 2024 | -443.41% |
| Dec 31, 2023 | -628.29% |
| Sep 30, 2023 | -624.11% |
| Jun 30, 2023 | -1,319.88% |
| Mar 31, 2023 | -562.77% |
| Dec 31, 2022 | -553.43% |
| Sep 30, 2022 | -541.72% |
| Jun 30, 2022 | -571.59% |
| Mar 31, 2022 | -523.36% |
| Dec 31, 2021 | -957.33% |
| Sep 30, 2021 | -837.55% |
| Jun 30, 2021 | -408.21% |
| Mar 31, 2021 | -419.81% |
Valion Bio Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=VBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();